Xin Liu

Dr. Xin Liu


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2011 in Allergy
Verified
Journal Article
Closed access
PDF file
XLXin Liu
Xin Liu
GWG. Wang
G. Wang
XHX. Hong
X. Hong
DWD. Wang
D. Wang
HTH.‐J. Tsai
H.‐J. Tsai
XWX. Wang
X. Wang

13 May 2016 in Biomolecules
Verified
Journal Article
Open access
PDF file
BKBradley Klemm
Bradley Klemm
NWNancy Wu
Nancy Wu
YCYu Chen
Yu Chen
XLXin Liu
Xin Liu
KKKipchumba J. Kaitany
Kipchumba J. Kaitany
CFCarol A. Fierke
Carol A. Fierke
Ribonuclease P (RNase P) is an essential endonuclease responsible for catalyzing 5’ end maturation in precursor transfer RNAs. Since its discovery in the 1970s, RNase P enzymes have been identified and studied throughout the three domains of life. Interestingly, RNase P is either RNA-based, with a catalytic RNA subunit, or a protein-only (PRORP) enzyme with differential evolutionary distribution. The available structural data, including the active site data, provides insight into catalysis and substrate recognition. The hydrolytic and kinetic mechanisms of the two forms of RNase P enzymes are similar, yet features unique to the RNA-based and PRORP enzymes are consistent with different evolutionary origins. The various RNase P enzymes, in addition to their primary role in tRNA 5’ maturation, catalyze cleavage of a variety of alternative substrates, indicating a diversification of RNase P function in vivo. The review concludes with a discussion of recent advances and interesting research directions in the field.

1 June 2012 in Epigenetics
Verified
Journal Article
Closed access
DWDeli Wang
Deli Wang
XLXin Liu
Xin Liu
YZYing Zhou
Ying Zhou
HXHehuang Xie
Hehuang Xie
XHXiumei Hong
Xiumei Hong
XWXiaobin Wang
Xiaobin Wang
Prenatal development and early childhood are critical periods for establishing the tissue-specific epigenome, and may have a profound impact on health and disease in later life. However, epigenomic...

9 January 2014 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KDKyle G. Daniels
Kyle G. Daniels
NTNam K. Tonthat
Nam K. Tonthat
DMDavid R. McClure
David R. McClure
YCYu-Chu Chang
Yu-Chu Chang
XLXin Liu
Xin Liu
TOTerrence G. Oas
Terrence G. Oas

31 January 2013 in Cell Cycle
Verified
Journal Article
Closed access
PDF file
XCXin Chen
Xin Chen
KRKiera Rycaj
Kiera Rycaj
XLXin Liu
Xin Liu
Dean G. TangDean G. Tang
Dean G. Tang
Prostate cancer (PCa) remains one of the most prevalent malignancies affecting men in the western world. The etiology for PCa development and molecular mechanisms underlying castration-resistant progression are incompletely understood. Emerging evidence from many tumor systems has shown the existence of distinct subpopulations of stem like-cancer cells termed cancer stem cells (CSCs), which may be involved in tumor initiation, progression, metastasis and therapy resistance. Prostate cancer stem cells (PCSCs) have also been identified using different experimental strategies in distinct model systems. In this brief review, we summarize our current knowledge of normal prostate stem/progenitor cells, highlight recent progress on PCSCs, expound on the potential cell-of-origin for PCa and discuss the involvement of PCSCs in PCa progression and castration resistance. Elucidation of the phenotypic and functional properties and molecular regulation of PCSCs will help us better understand PCa biology and may lead to development of novel therapeutics targeting castration-resistant PCa cells.

26 September 2007 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
HXHai-Yan Xie
Hai-Yan Xie
MXMin Xie
Min Xie
ZZZhi-Ling Zhang
Zhi-Ling Zhang
YLYan-Min Long
Yan-Min Long
XLXin Liu
Xin Liu
WZWuzong Zhou
Wuzong Zhou